Peer-influenced content. Sources you trust. No registration required. This is HCN.

Tocilizumab May Be Effective for Patients with COVID-19, Blood Cancer

Although researchers emphasized more research is necessary, a study in Blood Advances demonstrated that tocilizumab may be an effective treatment for patients with COVID-19 and hematologic malignancies.

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form